Subcutaneous Bortezomib in Multiple Myeloma Patients Induces Similar Therapeutic Response Rates as Intravenous Application But It Does Not Reduce the Incidence of Peripheral Neuropathy-Reference-Cited by-同舟云学术

Subcutaneous Bortezomib in Multiple Myeloma Patients Induces Similar Therapeutic Response Rates as Intravenous Application But It Does Not Reduce the Incidence of Peripheral Neuropathy

Published:2015-04-14 Issue:4 Volume:10 Page:e0123866
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Minarik Jiri,Pavlicek Petr,Pour Ludek,Pika Tomas,Maisnar Vladimir,Spicka Ivan,Jarkovsky Jiri,Krejci Marta,Bacovsky Jaroslav,Radocha Jakub,Straub Jan,Kessler Petr,Wrobel Marek,Walterova Lenka,Sykora Michal,Obernauerova Jarmila,Brozova Lucie,Gregora Evzen,Adamova Dagmar,Gumulec Jaromir,Adam Zdenek,Scudla Vlastimil,Hajek Roman,

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference26 articles.

1. Bortezomib or high-dose dexamethasone for relapsed multiple myeloma;PG Richardson;N Engl J Med,2005

2. Clinical Impact of Bortezomib in Frontline Regimens for Patients with Multiple Myeloma;R Manochakian;Oncologist,2007

3. Improved survival in multiple myeloma and the impact of novel therapies;SK Kumar;Blood,2008

4. Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study;P Moreau;Lancet Oncol,2011

5. Prospective comparison of subcutaneous versus intravenous administration of bortezomib in patients with multiple myeloma;P Moreau;Haematologica,2008

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is there a role for capsaicin in Cancer pain management?;Current Opinion in Supportive & Palliative Care;2024-09-12

2. Impact of Black Race on Peripheral Neuropathy in Patients With Newly Diagnosed Multiple Myeloma Receiving Bortezomib Induction;JCO Oncology Practice;2023-09

3. Bortezomib-Induced Reticular Eruption in Patient with Multiple Myeloma;Dermatopathology;2023-07-21

4. Investigation of the frequency of bortezomib neuropathy in patients with multiple myeloma diagnosis with normal and abnormal genetic characteristics;Journal of Oncology Pharmacy Practice;2022-10-13

5. Glutathione combined with mecobalamin in the treatment of chemotherapy-induced peripheral neuropathy in multiple myeloma: a retrospective clinical study;Annals of Palliative Medicine;2021-12